APA (7th ed.) Citation

Dearden, L., Shalet, N., Artenie, C., Mills, A., Jackson, C., Grant, L., & Gater, A. (2019). Fatigue, treatment satisfaction and health‐related quality of life among patients receiving novel drugs suppressing androgen signalling for the treatment of metastatic castrate‐resistant prostate cancer. European Journal of Cancer Care, 28(1), N.PAG. https://doi.org/10.1111/ecc.12949

Chicago Style (17th ed.) Citation

Dearden, Lindsay, Natalie Shalet, Cristiana Artenie, Andrew Mills, Claire Jackson, Laura Grant, and Adam Gater. "Fatigue, Treatment Satisfaction and Health‐related Quality of Life Among Patients Receiving Novel Drugs Suppressing Androgen Signalling for the Treatment of Metastatic Castrate‐resistant Prostate Cancer." European Journal of Cancer Care 28, no. 1 (2019): N.PAG. https://doi.org/10.1111/ecc.12949.

MLA (9th ed.) Citation

Dearden, Lindsay, et al. "Fatigue, Treatment Satisfaction and Health‐related Quality of Life Among Patients Receiving Novel Drugs Suppressing Androgen Signalling for the Treatment of Metastatic Castrate‐resistant Prostate Cancer." European Journal of Cancer Care, vol. 28, no. 1, 2019, p. N.PAG, https://doi.org/10.1111/ecc.12949.